Biological and therapeutic role of LSD1 in Alzheimer’s diseases
Alzheimer’s disease (AD) is a common chronic neurodegenerative disease characterized by cognitive learning and memory impairments, however, current treatments only provide symptomatic relief. Lysine-specific demethylase 1 (LSD1), regulating the homeostasis of histone methylation, plays an important...
Main Authors: | Yu Li, Yuanyuan Zhao, Xiaona Li, Liuqun Zhai, Hua Zheng, Ying Yan, Qiang Fu, Jinlian Ma, Haier Fu, Zhenqiang Zhang, Zhonghua Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1020556/full |
Similar Items
-
LSD1/KDM1A inhibitors in clinical trials: advances and prospects
by: Yuan Fang, et al.
Published: (2019-12-01) -
Expanding the Role of the Histone Lysine-Specific Demethylase LSD1 in Cancer
by: Barbara Majello, et al.
Published: (2019-03-01) -
Natural products as LSD1 inhibitors for cancer therapy
by: Yuan Fang, et al.
Published: (2021-03-01) -
LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials
by: Beatrice Noce, et al.
Published: (2023-02-01) -
LSD1/KDM1A, a Gate-Keeper of Cancer Stemness and a Promising Therapeutic Target
by: Panagiotis Karakaidos, et al.
Published: (2019-11-01)